SMYD3 and small cell lung carcinoma: Here, we observe that SMYD3 expression is highly upregulated in human SCLC, a cancer that is not induced by KRAS and nearly universally driven by inactivation of the TP53 and RB tumor suppressor genes, thereby suggesting additional and unidentified targets in this context.